Sangamo BioSciences | SGMO - Equity Capital And Reserves


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Sangamo BioSciences

Sangamo BioSciences reported $335.61M in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.


Equity Capital And Reserves Change
Alaunos Therapeutics Inc ZIOP:US USD 29.51M 9.05M
Alnylam Pharmaceuticals ALNY:US USD -259240000 101.02M
Amgen AMGN:US USD 5.35B 1.69B
Avrobio Inc AVRO:US USD 53M 22.37M
Bayer BAYN:GR EUR 40.86B 2.09B
BioCryst Pharmaceuticals BCRX:US USD -328287000 33.69M
Biogen BIIB:US USD 13.8B 398.7M
BioMarin Pharmaceutical BMRN:US USD 4.66B 55.89M
Bluebird Bio BLUE:US USD 354.74M 158.4M
Gilead Sciences GILD:US USD 20.94B 270M
GlaxoSmithKline GSK:LN GBP 11.82B 1.22B
Intercept Pharmaceuticals ICPT:US USD 67.18M 25.89M
Ionis Pharmaceuticals IONS:US USD 486.57M 86.32M
J&J JNJ:US USD 70.87B 5.94B
Karyopharm Therapeutics KPTI:US USD -45174000 28.52M
Novartis NOVN:VX USD 52.06B 7.28B
Regulus Therapeutics RGLS:US USD 26.6M 6.7M
Roche Holding ROG:VX CHF 27.99B 2.8B
Sangamo BioSciences SGMO:US USD 335.61M 40.65M
Sarepta Therapeutics SRPT:US USD 712.75M 327.8M
Ultragenyx Pharmaceutical RARE:US USD 220.48M 132.01M
Vertex Pharmaceuticals VRTX:US USD 14.43B 519.6M